Breast cancer continues to affect millions of people around the world—and for most, the diagnosis involves a hormone receptor-positive subtype.

TissueGnostics will be at the ASI 2025 meeting, 1–5 December in Perth, Australia. Join one of the region’s largest immunology events and meet our team to discuss your imaging needs.

TissueGnostics’ industry session at IUIS 2025 was a success, uniting immunologists around advances in spatial biology and AI-powered imaging. Thanks to Dr. Ecker, A/Prof. Mechtcheriakova, Prof. Batra, and all who joined us. Until next time!

The IF Artificial Skin App stratifies skin equivalents into dermis and epidermis, further dividing the epidermis into stratum corneum, suprabasal, and basal layers. It outputs area, mean staining intensity, nuclei counts, and % of marker-positive cells for each layer and sublayer. Read publication here 

TissueGnostics proudly participated in the recent mid-term meeting and first doctoral school of the Horizon Europe Marie Skłodowska-Curie Doctoral Network (DN) project eRaDicate.

Microscopy Australia’s MyScope platform offers free online modules with theory, simulators, and quizzes to support training in microscopy techniques.

TG joins SMART CRC as an industrial partner. This $238M initiative accelerates curative therapies for cancer, heart disease, Alzheimer’s, arthritis, and age-related conditions.

Chronic inflammatory diseases (CIDs) involve prolonged inflammation causing tissue damage and dysfunction.

Wang et al. used spatial transcriptomics to characterize subsets of tumor-associated macrophages (TAMs) known as monocyte-derived TAMs. They identified a cluster of hypoxia-TAM oversecreting adrenomedullin with multiplex immunostaining imaged with TissueFAXS Spectra, and StrataQuest for marker identification.

Tissue slide scanners combine whole-slide imaging, multispectral analysis, and AI-driven software to deliver quantitative, context-rich insights into cells, tissues, and microenvironments, advancing biomedical research.

The evolving understanding of cancer biology underscores the pivotal role of epigenetic modifications - heritable yet reversible changes in gene expression that do not alter the DNA sequence.

Dr. Diana Mechtcheriakova, Medical University of Vienna, presents research on lymphoid structures in systemic immunity and anti-cancer responses, with applications in colorectal cancer.

A new study shows PD-1+ Treg/CTL ratio combined with TLS predicts prognosis and treatment response in gastric cancer using mIF, TissueFAXS, and StrataQuest.

A research group in China analyzed CD39+CD8+ T cells in esophageal squamous cell carcinoma. Based on mIF-stained samples acquired on the TissueFAXS platform, they propose these cells as new markers for diagnosis and prognosis.

Researchers demonstrate TCL1A+ B cells drive TLS formation in OSCC and serve as a positive prognostic factor using mIF and TissueFAXS imaging.

Frontiers in Medicine launches a call for papers on cancer organoid co-culture models, with Prof. Uwe Ritter, Dr. Talita Glaser and Dr. Rupert Ecker (CEO, TissueGnostics) as topic editors. Deadline: 03.09.2025.

This webinar explores how tissue cytometry enables investigation of fatty liver disease, providing insights into liver pathology and immune interactions.

AI-powered tissue classification applies machine learning to identify and categorize tissue types. It supports consistent, quantitative analysis of morphology, tumor microenvironments, and disease processes in research and diagnostics.